Changes in Cardiovascular and Renal Biomarkers Associated with SGLT2 Inhibitors Treatment in Patients with Type 2 Diabetes Mellitus

Changes in Cardiovascular and Renal Biomarkers Associated with SGLT2 Inhibitors Treatment in Patients with Type 2 Diabetes Mellitus

Type 2 diabetes mellitus is a major health problem worldwide with a steadily increasing prevalence reaching epidemic proportions. The major concern is the increased morbidity and mortality due to diabetic complications. Traditional but also nontraditional risk factors have been proposed to explain t...

Full description

Bibliographic Details
Main Authors: Melpomeni Peppa, Aspasia Manta, Ioanna Mavroeidi, Athina Asimakopoulou, Alexandros Syrigos, Constantinos Nastos, Emmanouil Pikoulis, Anastasios Kollias
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Pharmaceutics
Subjects:
SGLT2 inhibitors
cardiorenal syndrome
cardiovascular biomarkers
renal biomarkers
type 2 diabetes mellitus
inflammation
Online Access:https://www.mdpi.com/1999-4923/15/11/2526

Internet

https://www.mdpi.com/1999-4923/15/11/2526

Similar Items